A risk factor for cardiovascular disease (CVD), mutant PCSK9, was expressed in APP/PS1 mice to study the CVD-Alzheimer’s disease inter-relationship. Cholesterol levels were elevated by 5-6-fold from 3 to 13 weeks after PCSK9 gene transfer. We tested whether hypercholesterolemia would increase amyloid-β plaques at a relatively early stage of plaque deposition. Plaque burden was increased in the hippocampus of PCSK9 treated mice though the increase was modest compared to the large elevation in cholesterol. Elevating cholesterol via gene transfer could be valuable in a variety of disease models compared to making crosses with germ-line transgenic mouse models of CVD.
StampferMJ (2006) Cardiovascular disease and Alzheimer’s disease: Common links. J Intern Med260, 211–223.
2.
LaunerLJ, HughesT, YuB, MasakiK, PetrovitchH, RossGW, WhiteLR (2010) Lowering midlife levels of systolic blood pressure as a public health strategy to reduce late-life dementia: Perspective from the Honolulu heart program/Honolulu Asia aging study. Hypertension55, 1352–1359.
3.
WhitmerRA, SidneyS, Claiborne JohnsonS, YaffeK (2005) Midlife cardiovascular risk factors and risk of dementia in late life. Neurology64, 277–281.
4.
YaffeK, Barrett-ConnorE, LinF, GradyD (2002) Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol59, 378–384.
ReedB, VilleneuveS, MackW, DeCarliC, ChuiHC, JagustW (2014) Associations between serum cholesterol levels and cerebral amyloidosis. JAMA Neurol71, 195–200.
7.
KangJH, LogroscinoG, De VivoI, HunterD, GrodsteinF (2005) Apolipoprotein E, cardiovascular disease and cognitive function in aging women. Neurobiol Aging26, 475–484.
8.
HaanMN, ShemanskiL, JagustWJ, ManolioTA, KullerL (1999) The role of APOE e4 in modulating effects of other risk factors for cognitive decline in elderly persons. J Am Med Assoc282, 40–46.
9.
ChuiHC, Ramirez-GomezL (2015) Clinical and imaging features of mixed Alzheimer and vascular pathologies. Alzheimers Res Ther7, 21.
10.
BjØrklundMM, HollensenAK, HagensenMK, Dagnæs-HansenF, ChristoffersenC, MikkelsenJG, BentzonJF (2014) Induction of atherosclerosis in mice and hamsters without germline genetic engineering. Circ Res114, 1684–1689.
11.
GrahamLC, HarderJM, SotoI, de VriesWN, JohnSWM, HowellGR (2016) Chronic consumption of a western diet induces robust glial activation in aging mice and in a mouse model of Alzheimer’s disease. Sci Rep6, 21568.
12.
ShieF-S, JinL-W, CookDG, LeverenzJB, LeBoeufRC (2002) Diet-induced hypercholesterolemia enhances brain A beta accumulation in transgenic mice. Neuroreport13, 455–459.
13.
BarronAM, RosarioER, ElteriefiR, PikeCJ (2013) Sex-specific effects of high fat diet on indices of metabolic syndrome in 3xTg-AD mice: Implications for Alzheimer’s disease. PLoS One8, 1–8.
14.
Martino AdamiPV, GaleanoP, WallingerML, QuijanoC, RabossiA, PaganoES, OlivarN, Reyes TosoC, CardinaliD, BruscoLI, Do CarmoS, RadiR, GevorkianG, CastañoEM, CuelloAC, MorelliL (2017) Worsening of memory deficit induced by energy-dense diet in a rat model of early-Alzheimer’s disease is associated to neurotoxic Aβ species and independent of neuroinflammation. Biochim Biophys Acta1863, 731–743.
15.
ThériaultP, ElAliA, RivestS (2016) High fat diet exacerbates Alzheimer’s disease-related pathology in APPswe/PS1 mice. Oncotarget7, 67808–67827.
16.
KnightEM, MartinsIVA, GümüsgözS, AllanSM, LawrenceCB (2014) High-fat diet-induced memory impairment in triple-transgenic Alzheimer’s disease (3xTgAD) mice is independent of changes in amyloid and tau pathology. Neurobiol Aging35, 1821–1832.
KleinRL, DaytonRD, TatomJB, HendersonKM, HenningPP (2008) AAV8, 9, Rh10, Rh43 vector gene transfer in the rat brain: Effects of serotye, promoter and purification method. Mol Ther16, 89–96.
19.
JacksonKL, DaytonRD, DevermanBE, KleinRL (2016) Better targeting, better efficiency for wide-scale neuronal transduction with the synapsin promoter and AAV-PHP.B. Front Mol Neurosci9, 1–11.
20.
KleinRL, LinW-L, DicksonDW, LewisJ, HuttonM, DuffK, MeyerEM, KingMA (2004) Rapid neurofibrillary tangle formation after localized gene transfer of mutated tau. Am J Pathol164, 347–353.
GramesMS, JacksonKL, DaytonRD, StanfordJA, KleinRL (2017) Methods and tips for intous administration of adeno-associated virus to rats and evaluation of central nervous system transduction. J Vis Exp126, 1–7.
23.
KalariaRN (1997) Cerebrovascular degeneration is related to amyloid-β protein deposition in Alzheimer’s disease. Ann N Y Acad Sci826, 263–271.
24.
LambriM, DjurovicV, KibbleM, CairnsN, Al-SarrajS (2001) Specificity and sensitivity of betaAPP in head injury. Clin Neuropathol20, 263–271.
